NR3C2 and chronic kidney disease: Of note, metyrapone, a potent inhibitor of 11-beta hydroxysteriod dehydroger and mineralocorticoid receptor as well as cytochrome P450, showed the highest negative enrichment score in cMAP analysis, implying that it maximally reversed the expression of upregulated CKD-related pathogenic genes in CAVD.